glp 1 parkinson's Repurposing GLP-1 Receptor Agonists for Disease: Current Evidence and Future Opportunities | Pharmaceutical Medicine GLP-1 drug shows little benefit

This is likely due to their role in dampening the brains reward circuits

This results in hard, dry stools that are difficult to pass

Obesity Drug Market Overview and Growth Potential The US obesity drug market is on a meteoric rise, projected to soar past USD 73 billion by 2034

[DOI] [PubMed] [Google Scholar] 55.Tripathy NR, Basha S, Jain R, Shetty S, Ramachandran A

[DOI] [PubMed] [Google Scholar] 110.Exenatide once weekly SPC

The Bruchs membrane opening (BMO) diameter, determined as the mean of two linear scans passing vertically and horizontally through the ONH captured using SD-OCT, was 1749 m in the RE and 1660 m in the LE